SCHEMBL22158403

SCHEMBL22158403

N#Cc1c(-n2c3cc(-n4c5ccccc5c5ccccc54)ccc3c3ccc(-n4c5ccccc5c5ccccc54)cc32)cc(-c2cc(F)cc(F)c2)cc1-n1c2cc(-n3c4ccccc4c4ccccc43)ccc2c2ccc(-n3c4ccccc4c4ccccc43)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
ATM Q13315 1/20 0.36
PGR P06401 2/20 0.34
ALDH1A1 P00352 3/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
EGFR P00533 1/20 0.31
SRC P12931 1/20 0.31
KCNJ5 P48544 1/20 0.31
KCNJ3 P48549 1/20 0.31
KCNQ1 P51787 1/20 0.31
CACNA1C Q13936 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22158400 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMPGRALDH1A1
SCHEMBL22158402 0.92 KDM4E (0.36) KDM4EL3MBTL1ATMPGRALDH1A1
SCHEMBL22158401 0.92 KDM4E (0.36) KDM4EL3MBTL1ATMPGRALDH1A1
SCHEMBL22158296 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMPGRALDH1A1
SCHEMBL22155913 0.88 PGR (0.39) KDM4EL3MBTL1ATMPGRHPGD
SCHEMBL22156717 0.88 PDE9A (0.37) KDM4EL3MBTL1ATMALDH1A1LMNA
SCHEMBL22158452 0.87 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1LMNA
SCHEMBL22158453 0.87 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1LMNA
SCHEMBL21414277 0.86 KDM4E (0.37) KDM4EL3MBTL1ATMPGRALDH1A1
SCHEMBL22158412 0.85 KDM4E (0.34) KDM4EL3MBTL1ATMALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 KDM4E 4239/4885L3MBTL1 4126/4885ATM 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.